SCHEMBL21452445

SCHEMBL21452445

CC(=O)N[C@H]1CCC[C@H](NC(C)(C)C)C1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.49
KDM4E B2RXH2 1/20 0.49
ATM Q13315 2/20 0.43
BTK Q06187 1/20 0.41
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37
TLR4 O00206 1/20 0.37
CA12 O43570 1/20 0.37
CA9 Q16790 1/20 0.37
MTNR1A P48039 1/20 0.37
MTNR1B P49286 1/20 0.37
EPHX1 P07099 3/20 0.36
PDK1 Q15118 1/20 0.35
PDK2 Q15119 1/20 0.35
PDK3 Q15120 1/20 0.35
PDK4 Q16654 1/20 0.35
GRM5 P41594 1/20 0.34
PSEN1 P49768 3/20 0.33
PSEN2 P49810 3/20 0.33
APH1B Q8WW43 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12928798 1.00 ALDH1A1 (0.49) ALDH1A1KDM4EATMBTKCA1
SCHEMBL21452446 1.00 ALDH1A1 (0.49) ALDH1A1KDM4EATMBTKCA1
SCHEMBL21452437 0.92 ATM (0.46) ALDH1A1KDM4EATMBTKTLR4
SCHEMBL21452633 0.92 ATM (0.46) ALDH1A1KDM4EATMBTKTLR4
SCHEMBL12219598 0.92 ATM (0.46) ALDH1A1KDM4EATMBTKTLR4
SCHEMBL283828 0.86 ALDH1A1 (0.61) ALDH1A1KDM4EATMBTKCA1
SCHEMBL283971 0.86 ALDH1A1 (0.61) ALDH1A1KDM4EATMBTKCA1
SCHEMBL283972 0.86 ALDH1A1 (0.61) ALDH1A1KDM4EATMBTKCA1
SCHEMBL283829 0.86 ALDH1A1 (0.61) ALDH1A1KDM4EATMBTKCA1
SCHEMBL20549583 0.85 BTK (0.45) ALDH1A1KDM4EBTKEPHX1PDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210340121-A1 SUBSTITUTED PYRIDINE AND PYRIMIDINES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2021-11-04 US disclosed
US-11008302-B2 Substituted pyridine and pyrimidines and their use as GluN2B receptor modulators JANSSEN PHARMACEUTICA NV (BE) 2021-05-18 US disclosed
US-20190308950-A1 SUBSTITUTED PYRIDINE AND PYRIMIDINES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2019-10-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190308950-A1 SUBSTITUTED PYRIDINE AND PYRIMIDINES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS GRIN2B, GRIN2A, GRIN3B ALDH1A1 2145/4885KDM4E 2973/4885ATM 3187/4885
US-20210340121-A1 SUBSTITUTED PYRIDINE AND PYRIMIDINES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS GRIN2B, GRIN2A, GRIN3B ALDH1A1 2145/4885KDM4E 2973/4885ATM 3187/4885
US-11008302-B2 Substituted pyridine and pyrimidines and their use as GluN2B receptor modulators GRIN2B, GRIN2A, GRIN3B ALDH1A1 2074/4885KDM4E 3194/4885ATM 3182/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.